Pharming Group to participate in February investor conference

Rhea-AI Summary

Pharming Group (Euronext Amsterdam: PHARM/Nasdaq: PHAR) has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference, scheduled for February 11-12, 2025. The virtual event will feature a presentation by CEO Sijmen de Vries and CMO Anurag Relan on Wednesday, February 12 at 08:40 ET/14:40 CET.

Investors can access both the live webcast and replay of the presentation through the 'Upcoming Events' and 'News' sections of Pharming's website. Those interested in scheduling one-to-one meetings with Pharming's management team can contact the company's Investor Relations team or their Oppenheimer representative.

Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of February:

• Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025
  Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET/14:40 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Oppenheimer representative.
 

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming attending Investor Conferences February 2025_EN_10FEB25

FAQ

When is Pharming Group (PHARM) presenting at the Oppenheimer Healthcare Conference 2025?

Pharming Group will present at the Oppenheimer Healthcare Conference on Wednesday, February 12, 2025, at 08:40 ET/14:40 CET.

How can investors watch Pharming Group's (PHARM) Oppenheimer Conference presentation?

Investors can watch the live webcast and replay through the 'Upcoming Events' and 'News' sections of Pharming's website.

Who will represent Pharming Group (PHARM) at the 2025 Oppenheimer Healthcare Conference?

CEO Sijmen de Vries and CMO Anurag Relan will represent Pharming Group at the conference.

How can investors schedule meetings with Pharming Group (PHARM) management during the Oppenheimer Conference?

Investors can schedule one-to-one meetings by contacting Pharming's Investor Relations team at investor@pharming.com or through their Oppenheimer representative.